mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.088 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
Tipifarnib |
FIMM |
pan-cancer |
AAC |
-0.2 |
0.2 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.2 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BI-2536 |
GDSC1000 |
pan-cancer |
AAC |
0.086 |
0.2 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.2 |